SlideShare a Scribd company logo
BASICS OF MEDICAL STATISTICS
SHARED FROM TINY NAIR (CSI UPDATE 2016)
KEYWORDS
• PROBABILITY: (P)
• SAMPLE SIZE
• EFFECT SIZE
• ODDS AND ODDS RATIO
• RISK AND RISK RATIO
• STANDARD DEVIATION
• HOW TO USE SD INTELLIGENTLY
• CONFIDENCE INTERVAL
• HOW TO INTERPRET A CLINICAL TRIAL
• CALCULATE NNT
• TYPES OF TRIAL
PROBABILITY
• Probability is an indicator of how much of the data can happen just by chance. p value of less
than (<) 0.5 p <0.5 = 5/10 = ½ indicates that there is 50% chance that the result may be
happening just because of a chance
• p = 0.05 = 5/100 = 1/20
• To be statistically significant look for a p value of at least less than 0.05
• p <0.05 Statistically significant
• p <0.01 Highly significant
• p <0.001 Very highly significant
• Always look at the sample size /confidence interval (CI) before giving a judgment on p value
alone
SAMPLE & EFFECT SIZE
• The value of p is inversely proportional to effect size and sample size
• This means if we are testing the effects of a new blood pressure medicine is reducing
blood pressure by 20 mm Hg, but was tested in only 100 patients, the p value may be
significant but the sample size is too small to be significant. In similar lines, a drug
reducing blood pressure by merely 1 mm Hg may return a significant p value, when
tested in 1 million populations but the effect size is too small to be worthwhile
statistically
• To avoid statistical error, today the statistician calculates the minimum sample
size that would be required to show a difference of results depending on the
prevalence of the event rate in the natural course of the disease in the population
being studied
ODDS
• The term Odds means a disease or effect happening versus not happening
• Supposing that 10 out of 100 patients of acute myocardial infarction would die, the
odds are 10 will die and 90 will live. So, the Odds are 10/90 = 0.11 (Happens/Not
Happen) Now a medical paper says that there is a new drug ABC shows benefit in
reducing death rate of myocardial infarction. On being treated with the new drug, only
2 out of 100 acute myocardial infarction cases died. This means 2 dies and 98 live. So
Odds for this new treatment are 2/98 = 0.02
ODD RATIO
• Odds Ratio = control odds/Treatment Odds = 0.11/0.02 = 5.5
• This means treatment with this new drug reduces chance of death by 5.5 times
RISK AND RISK RATIO
• Risk is a similar term that means disease or effect out of the entire population. In
the same example of the heart attack above, the risk of death is 10 out of 100
(not 10/90 as in odds) Risk of death in MI 10/100 = 0.10 (Happens/Total) Similarly
risk after being administered ABC has a risk of 2/100 = 0.02
RISK RATIO
• Risk ratio = 0.10/0.02 = 5 (very close to odds ratio)
• In most cases, odds ratio and risk ratio is close
• Now consider, unlike the example of myocardial infarction, a disease has a
mortality of 90% (90 out of 100 die). In such a scenario, the odds would be 90/10
(died 10 survived) returning a value of odds of 9, while the risk ratio would be
90/100 = 0.9. So, dichotomy between odds and risk indicate high event rate in
control group and this may corrupt a study
STANDARD DEVIATION
• Any physiological parameter will have variation from people to people
• If we take sufficient number of people and plot their values, they tend to follow a
normal or nominal distribution (a Bell-shaped curve)
• The central line in the curve is the mean (akin to arithmetic average)
• As we go farther away from the mean, the degree of deviation (from mean)
increases
• One standard deviation (1 SD) covers 68.2% of data spread from mean. 2SD
covers more, up to 95.4% data and 3 SD covers almost a whooping 99.7% data
EXAMPLE OF S.D
• Serum cholesterol in a population of a town of 8,000 people . Most people have a
mean cholesterol of 200 mg (Central Line), while some as low as 100 and as high
as 300. Standard deviation is 25 mg of cholesterol. This means if we look at ± 1
standard deviation the value would range from 175 to 225. One standard
deviation constitutes of 68.2% of the population data in any normal distribution
(5456 people) the entire dark group. If we take two standard deviation it covers
the cholesterol values from 150 to 250 covering 95.4% of the population (7,632
people). The dark and light group. Three standard deviation covers 99.7% of the
population from the cholesterol level of 100–300 (7,976 of 8,000). This means
three standard deviation practically cover entire data set.=The whole shaded area.
CONFIDENCE INTERVAL
• Confidence interval = 0.83 (CI 0.88–0.98) The upper value is below 1. So, it is
statistically significant. However, clinical significance of a value is considered only
when it is below 0.85. So, in this case, it is statistically significant, but clinically not
significant
• Confidence interval = 0.78 (CI 0.76–0.97) Here the upper value is below 1, while the
lower one is below 0.85. Hence, it is statistically significant and may be clinically
significant
• Confidence interval = 0.78 (CI 0.57–1.12) Here the value wraps around 1, hence
statistically not significant. However, since the lower value is below 0.85, it may still be
clinically significant. In such cases, a repeat trial is indicated.
• Confidence interval = 0.59 (CI 0.43 – 0.76) In this case, both the upper and lower
values are below 0.85, so it is statistically as well as clinically significant
EXAMPLE
• Journal Report New Drug XYZ Reduces Heart Failure Mortality by 20%
• Study with a new drug XYZ’ for heart failure.
• 5/1,000 patients died with standard care at end of 1 year=0.5%
• 4/1,000 patients on XYZ died at end of 1 year=0.4%
• Absolute risk reduction (ARR) – the real thing = 0.5 – 0.4 = 0.1%
• Relative risk reduction (RRR) = 0.1/0.5 = 20%
• The logical next step would be to check for p value, NNT and CI Look for p value
•
CONTD……EXAMPLE
• Accept if p < 0.05
• Many noninferiority trials try to show weather the drug or treatment is “not worse”
compared to the present gold standard, but do not ask whether it is better or not. This
means it is checking one end (single tail) of the standard bell curve and not both the
ends (double tails). A single tailed trial needs a higher p value to be significant (at least
p, 0.01)
• Ask for confidence interval, if wraps around unity
• Reject it (e.g. 0.56–1.23 goes to junk)
• Enquire pre-specified endpoints.
NNT
• Calculate NNT NNT is number needed to treat to prevent one event (let one
Death) NNT is calculated by dividing 100/APR = 100/0.1 = 1000 So, you need to
treat 1,000 patients to prevent one death
• NNT is significant (acceptable) if more than 50
• Here ,it is 1,000, so not significant.
TYPES OF TRIAL
• Observational studies: prevalence of a disease or its complications
• Interventional studies: Randomized and placebo- controlled for guideline
formation
TYPES OF TRIALS
CONCLUSION
• A step-by step approach to look for
• ARR
• p value
• NNT
• CI
• Can simply data
BIBLIOGRAPHY
1. Harris M, Taylor G, Dunitz M. Medical Statistics Made Easy. London and New
York: Martin Dunitz; 2003.
2. Magnello E, Loon BV. Statistics, A graphic Guide. Icon Books, UK.
3. Mayer D. Essential Evidenced Based Medicine, Dan Mayer, Cambridge
medicine, 2nd edn. US: Cambridge University Press; 2009.
4. Nair T. Medical Statistics and Clinical Trials, 1st edn. Wiley Blackwell. 5. Sanjay
K, Diamond G. Trial and error: how to avoid commonly encountered limitations
of published clinical trials, J Am Coll Cardiol. 2010;55:415-27.
DO YOU KNOW WHAT DOES CITY MEAN ?
• C:Cutting
• I:Innocent
• T:Trees
• Y:Yatra

More Related Content

What's hot

Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute RiskTauseef Jawaid
 
Odds ratios (Basic concepts)
Odds ratios (Basic concepts)Odds ratios (Basic concepts)
Odds ratios (Basic concepts)
Tarekk Alazabee
 
Chapter1:introduction to medical statistics
Chapter1:introduction to medical statisticsChapter1:introduction to medical statistics
Chapter1:introduction to medical statisticsghalan
 
Predictive value and likelihood ratio
Predictive value and likelihood ratio Predictive value and likelihood ratio
Predictive value and likelihood ratio
Abino David
 
How to read a forest plot?
How to read a forest plot?How to read a forest plot?
How to read a forest plot?Samir Haffar
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
Subraham Pany
 
Sample size calculations
Sample size calculationsSample size calculations
Tests of diagnostic accuracy
Tests of diagnostic accuracyTests of diagnostic accuracy
Tests of diagnostic accuracySimba Takuva
 
Attack rate
Attack rateAttack rate
Attack rate
sonytopp
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATION
Kanhu Charan
 
Sample size determination
Sample size determinationSample size determination
Sample size determination
Gopal Kumar
 
Sensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictiveSensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictive
Musthafa Peedikayil
 
Kaplan Meier Survival Curve Analysis
Kaplan Meier Survival Curve Analysis Kaplan Meier Survival Curve Analysis
Kaplan Meier Survival Curve Analysis
Nermin Osman
 
Sample size calculation
Sample size calculationSample size calculation
Sample size calculation
Santam Chakraborty
 
Validity of a screening test
Validity of a screening testValidity of a screening test
Validity of a screening test
drkulrajat
 
Hazard ratios
Hazard ratiosHazard ratios
Hazard ratios
Terry Shaneyfelt
 
Advance concepts in screening
Advance concepts in screeningAdvance concepts in screening
Advance concepts in screening
Mohammad Aslam Shaiekh
 

What's hot (20)

Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute Risk
 
Odds ratios (Basic concepts)
Odds ratios (Basic concepts)Odds ratios (Basic concepts)
Odds ratios (Basic concepts)
 
Chapter1:introduction to medical statistics
Chapter1:introduction to medical statisticsChapter1:introduction to medical statistics
Chapter1:introduction to medical statistics
 
Predictive value and likelihood ratio
Predictive value and likelihood ratio Predictive value and likelihood ratio
Predictive value and likelihood ratio
 
How to read a forest plot?
How to read a forest plot?How to read a forest plot?
How to read a forest plot?
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
 
Sample size calculations
Sample size calculationsSample size calculations
Sample size calculations
 
Tests of diagnostic accuracy
Tests of diagnostic accuracyTests of diagnostic accuracy
Tests of diagnostic accuracy
 
Attack rate
Attack rateAttack rate
Attack rate
 
Survival analysis
Survival  analysisSurvival  analysis
Survival analysis
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATION
 
Sample size determination
Sample size determinationSample size determination
Sample size determination
 
Sample size calculation
Sample size calculationSample size calculation
Sample size calculation
 
Sensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictiveSensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictive
 
Kaplan Meier Survival Curve Analysis
Kaplan Meier Survival Curve Analysis Kaplan Meier Survival Curve Analysis
Kaplan Meier Survival Curve Analysis
 
Sample size calculation
Sample size calculationSample size calculation
Sample size calculation
 
Validity of a screening test
Validity of a screening testValidity of a screening test
Validity of a screening test
 
Hazard ratios
Hazard ratiosHazard ratios
Hazard ratios
 
Incidence And Prevalence
Incidence And PrevalenceIncidence And Prevalence
Incidence And Prevalence
 
Advance concepts in screening
Advance concepts in screeningAdvance concepts in screening
Advance concepts in screening
 

Similar to Basics of medical statistics

Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statisticsHesham Gaber
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
Hesham Al-Inany
 
How to do the maths
How to do the mathsHow to do the maths
How to do the maths
Ahmed Elfaitury
 
statistics for MEDICAL RESEARH.... .pptx
statistics for MEDICAL RESEARH.... .pptxstatistics for MEDICAL RESEARH.... .pptx
statistics for MEDICAL RESEARH.... .pptx
dhivyaramesh95
 
Statistics
StatisticsStatistics
Statistics
fracpractice
 
Imran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysis
Imran Rizvi
 
Epidemological methods
Epidemological methodsEpidemological methods
Epidemological methods
Kundan Singh
 
Summarizing data
Summarizing dataSummarizing data
Summarizing data
Dr Lipilekha Patnaik
 
Introduction to medical statistics
Introduction to medical statistics Introduction to medical statistics
Introduction to medical statistics
Mohamed Alhelaly
 
RMH Concise Revision Guide - the Basics of EBM
RMH Concise Revision Guide -  the Basics of EBMRMH Concise Revision Guide -  the Basics of EBM
RMH Concise Revision Guide - the Basics of EBM
AyselTuracli
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...cambridgeWD
 
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...cambridgeWD
 
Clinical research ( Medical stat. concepts)
Clinical research ( Medical stat. concepts)Clinical research ( Medical stat. concepts)
Clinical research ( Medical stat. concepts)
Mohamed Fahmy Dehim
 
Single sample z test - explain (final)
Single sample z test - explain (final)Single sample z test - explain (final)
Single sample z test - explain (final)
CTLTLA
 
Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015
Isla Kuhn
 
Biostatistics.pptx
Biostatistics.pptxBiostatistics.pptx
Biostatistics.pptx
SagarAGavankar
 
Bio statistical analysis in clinical research
Bio statistical analysis  in clinical research  Bio statistical analysis  in clinical research
Bio statistical analysis in clinical research
Helwan University
 
Risk Comparison
Risk ComparisonRisk Comparison
Risk Comparison
Weam Banjar
 
Understanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology studyUnderstanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology study
kamolwantnok
 

Similar to Basics of medical statistics (20)

Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
How to do the maths
How to do the mathsHow to do the maths
How to do the maths
 
statistics for MEDICAL RESEARH.... .pptx
statistics for MEDICAL RESEARH.... .pptxstatistics for MEDICAL RESEARH.... .pptx
statistics for MEDICAL RESEARH.... .pptx
 
Statistics
StatisticsStatistics
Statistics
 
Imran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysisImran rizvi statistics in meta analysis
Imran rizvi statistics in meta analysis
 
Epidemological methods
Epidemological methodsEpidemological methods
Epidemological methods
 
Summarizing data
Summarizing dataSummarizing data
Summarizing data
 
Introduction to medical statistics
Introduction to medical statistics Introduction to medical statistics
Introduction to medical statistics
 
RMH Concise Revision Guide - the Basics of EBM
RMH Concise Revision Guide -  the Basics of EBMRMH Concise Revision Guide -  the Basics of EBM
RMH Concise Revision Guide - the Basics of EBM
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
 
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
 
Clinical research ( Medical stat. concepts)
Clinical research ( Medical stat. concepts)Clinical research ( Medical stat. concepts)
Clinical research ( Medical stat. concepts)
 
Single sample z test - explain (final)
Single sample z test - explain (final)Single sample z test - explain (final)
Single sample z test - explain (final)
 
Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015
 
Biostatistics.pptx
Biostatistics.pptxBiostatistics.pptx
Biostatistics.pptx
 
Bio statistical analysis in clinical research
Bio statistical analysis  in clinical research  Bio statistical analysis  in clinical research
Bio statistical analysis in clinical research
 
Risk Comparison
Risk ComparisonRisk Comparison
Risk Comparison
 
Understanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology studyUnderstanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology study
 

More from Ramachandra Barik

Willens's syndrome.pptx
Willens's syndrome.pptxWillens's syndrome.pptx
Willens's syndrome.pptx
Ramachandra Barik
 
Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptx
Ramachandra Barik
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptx
Ramachandra Barik
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdf
Ramachandra Barik
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After Splenectomy
Ramachandra Barik
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
Ramachandra Barik
 
MISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptxMISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptx
Ramachandra Barik
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
Ramachandra Barik
 
Arrythmia-IV.pptx
Arrythmia-IV.pptxArrythmia-IV.pptx
Arrythmia-IV.pptx
Ramachandra Barik
 
Arrythmia-III.pptx
Arrythmia-III.pptxArrythmia-III.pptx
Arrythmia-III.pptx
Ramachandra Barik
 
Arrythmia-II.pptx
Arrythmia-II.pptxArrythmia-II.pptx
Arrythmia-II.pptx
Ramachandra Barik
 
Arrythmia-I.pptx
Arrythmia-I.pptxArrythmia-I.pptx
Arrythmia-I.pptx
Ramachandra Barik
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Ramachandra Barik
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancy
Ramachandra Barik
 
Coronary guidewire
Coronary guidewireCoronary guidewire
Coronary guidewire
Ramachandra Barik
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomography
Ramachandra Barik
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
Ramachandra Barik
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human development
Ramachandra Barik
 
Intra aortic balloon pump
Intra aortic balloon pumpIntra aortic balloon pump
Intra aortic balloon pump
Ramachandra Barik
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendons
Ramachandra Barik
 

More from Ramachandra Barik (20)

Willens's syndrome.pptx
Willens's syndrome.pptxWillens's syndrome.pptx
Willens's syndrome.pptx
 
Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptx
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptx
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdf
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After Splenectomy
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
 
MISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptxMISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptx
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
 
Arrythmia-IV.pptx
Arrythmia-IV.pptxArrythmia-IV.pptx
Arrythmia-IV.pptx
 
Arrythmia-III.pptx
Arrythmia-III.pptxArrythmia-III.pptx
Arrythmia-III.pptx
 
Arrythmia-II.pptx
Arrythmia-II.pptxArrythmia-II.pptx
Arrythmia-II.pptx
 
Arrythmia-I.pptx
Arrythmia-I.pptxArrythmia-I.pptx
Arrythmia-I.pptx
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancy
 
Coronary guidewire
Coronary guidewireCoronary guidewire
Coronary guidewire
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomography
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human development
 
Intra aortic balloon pump
Intra aortic balloon pumpIntra aortic balloon pump
Intra aortic balloon pump
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendons
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 

Basics of medical statistics

  • 1. BASICS OF MEDICAL STATISTICS SHARED FROM TINY NAIR (CSI UPDATE 2016)
  • 2. KEYWORDS • PROBABILITY: (P) • SAMPLE SIZE • EFFECT SIZE • ODDS AND ODDS RATIO • RISK AND RISK RATIO • STANDARD DEVIATION • HOW TO USE SD INTELLIGENTLY • CONFIDENCE INTERVAL • HOW TO INTERPRET A CLINICAL TRIAL • CALCULATE NNT • TYPES OF TRIAL
  • 3. PROBABILITY • Probability is an indicator of how much of the data can happen just by chance. p value of less than (<) 0.5 p <0.5 = 5/10 = ½ indicates that there is 50% chance that the result may be happening just because of a chance • p = 0.05 = 5/100 = 1/20 • To be statistically significant look for a p value of at least less than 0.05 • p <0.05 Statistically significant • p <0.01 Highly significant • p <0.001 Very highly significant • Always look at the sample size /confidence interval (CI) before giving a judgment on p value alone
  • 4. SAMPLE & EFFECT SIZE • The value of p is inversely proportional to effect size and sample size • This means if we are testing the effects of a new blood pressure medicine is reducing blood pressure by 20 mm Hg, but was tested in only 100 patients, the p value may be significant but the sample size is too small to be significant. In similar lines, a drug reducing blood pressure by merely 1 mm Hg may return a significant p value, when tested in 1 million populations but the effect size is too small to be worthwhile statistically • To avoid statistical error, today the statistician calculates the minimum sample size that would be required to show a difference of results depending on the prevalence of the event rate in the natural course of the disease in the population being studied
  • 5. ODDS • The term Odds means a disease or effect happening versus not happening • Supposing that 10 out of 100 patients of acute myocardial infarction would die, the odds are 10 will die and 90 will live. So, the Odds are 10/90 = 0.11 (Happens/Not Happen) Now a medical paper says that there is a new drug ABC shows benefit in reducing death rate of myocardial infarction. On being treated with the new drug, only 2 out of 100 acute myocardial infarction cases died. This means 2 dies and 98 live. So Odds for this new treatment are 2/98 = 0.02
  • 6. ODD RATIO • Odds Ratio = control odds/Treatment Odds = 0.11/0.02 = 5.5 • This means treatment with this new drug reduces chance of death by 5.5 times
  • 7. RISK AND RISK RATIO • Risk is a similar term that means disease or effect out of the entire population. In the same example of the heart attack above, the risk of death is 10 out of 100 (not 10/90 as in odds) Risk of death in MI 10/100 = 0.10 (Happens/Total) Similarly risk after being administered ABC has a risk of 2/100 = 0.02
  • 8. RISK RATIO • Risk ratio = 0.10/0.02 = 5 (very close to odds ratio) • In most cases, odds ratio and risk ratio is close • Now consider, unlike the example of myocardial infarction, a disease has a mortality of 90% (90 out of 100 die). In such a scenario, the odds would be 90/10 (died 10 survived) returning a value of odds of 9, while the risk ratio would be 90/100 = 0.9. So, dichotomy between odds and risk indicate high event rate in control group and this may corrupt a study
  • 9. STANDARD DEVIATION • Any physiological parameter will have variation from people to people • If we take sufficient number of people and plot their values, they tend to follow a normal or nominal distribution (a Bell-shaped curve) • The central line in the curve is the mean (akin to arithmetic average) • As we go farther away from the mean, the degree of deviation (from mean) increases • One standard deviation (1 SD) covers 68.2% of data spread from mean. 2SD covers more, up to 95.4% data and 3 SD covers almost a whooping 99.7% data
  • 10. EXAMPLE OF S.D • Serum cholesterol in a population of a town of 8,000 people . Most people have a mean cholesterol of 200 mg (Central Line), while some as low as 100 and as high as 300. Standard deviation is 25 mg of cholesterol. This means if we look at ± 1 standard deviation the value would range from 175 to 225. One standard deviation constitutes of 68.2% of the population data in any normal distribution (5456 people) the entire dark group. If we take two standard deviation it covers the cholesterol values from 150 to 250 covering 95.4% of the population (7,632 people). The dark and light group. Three standard deviation covers 99.7% of the population from the cholesterol level of 100–300 (7,976 of 8,000). This means three standard deviation practically cover entire data set.=The whole shaded area.
  • 11.
  • 12. CONFIDENCE INTERVAL • Confidence interval = 0.83 (CI 0.88–0.98) The upper value is below 1. So, it is statistically significant. However, clinical significance of a value is considered only when it is below 0.85. So, in this case, it is statistically significant, but clinically not significant • Confidence interval = 0.78 (CI 0.76–0.97) Here the upper value is below 1, while the lower one is below 0.85. Hence, it is statistically significant and may be clinically significant • Confidence interval = 0.78 (CI 0.57–1.12) Here the value wraps around 1, hence statistically not significant. However, since the lower value is below 0.85, it may still be clinically significant. In such cases, a repeat trial is indicated. • Confidence interval = 0.59 (CI 0.43 – 0.76) In this case, both the upper and lower values are below 0.85, so it is statistically as well as clinically significant
  • 13.
  • 14. EXAMPLE • Journal Report New Drug XYZ Reduces Heart Failure Mortality by 20% • Study with a new drug XYZ’ for heart failure. • 5/1,000 patients died with standard care at end of 1 year=0.5% • 4/1,000 patients on XYZ died at end of 1 year=0.4% • Absolute risk reduction (ARR) – the real thing = 0.5 – 0.4 = 0.1% • Relative risk reduction (RRR) = 0.1/0.5 = 20% • The logical next step would be to check for p value, NNT and CI Look for p value •
  • 15. CONTD……EXAMPLE • Accept if p < 0.05 • Many noninferiority trials try to show weather the drug or treatment is “not worse” compared to the present gold standard, but do not ask whether it is better or not. This means it is checking one end (single tail) of the standard bell curve and not both the ends (double tails). A single tailed trial needs a higher p value to be significant (at least p, 0.01) • Ask for confidence interval, if wraps around unity • Reject it (e.g. 0.56–1.23 goes to junk) • Enquire pre-specified endpoints.
  • 16. NNT • Calculate NNT NNT is number needed to treat to prevent one event (let one Death) NNT is calculated by dividing 100/APR = 100/0.1 = 1000 So, you need to treat 1,000 patients to prevent one death • NNT is significant (acceptable) if more than 50 • Here ,it is 1,000, so not significant.
  • 17. TYPES OF TRIAL • Observational studies: prevalence of a disease or its complications • Interventional studies: Randomized and placebo- controlled for guideline formation
  • 19. CONCLUSION • A step-by step approach to look for • ARR • p value • NNT • CI • Can simply data
  • 20. BIBLIOGRAPHY 1. Harris M, Taylor G, Dunitz M. Medical Statistics Made Easy. London and New York: Martin Dunitz; 2003. 2. Magnello E, Loon BV. Statistics, A graphic Guide. Icon Books, UK. 3. Mayer D. Essential Evidenced Based Medicine, Dan Mayer, Cambridge medicine, 2nd edn. US: Cambridge University Press; 2009. 4. Nair T. Medical Statistics and Clinical Trials, 1st edn. Wiley Blackwell. 5. Sanjay K, Diamond G. Trial and error: how to avoid commonly encountered limitations of published clinical trials, J Am Coll Cardiol. 2010;55:415-27.
  • 21. DO YOU KNOW WHAT DOES CITY MEAN ? • C:Cutting • I:Innocent • T:Trees • Y:Yatra